Sanofi: tender offer on Ablymx to begin on 4 April
(CercleFinance.com) - Today Sanofi and Ablynx have said that the previously announced tender offers to acquire all of the outstanding shares (including shares represented by American Depositary Shares (“ADS”)), warrants and convertible bonds of Ablynx will be launched on 4 April 2018.
The offer will be launched at a price of 45.00 euros per share or ADS, 18.66 euros - 41.79 euros per warrant, 393,700.78 euros per convertible bond.
"With Ablynx's innovative Nanobody® technology platform, Sanofi will continue to advance the strategic transformation of its Research and Development strategy, expanding its late-stage pipeline and strengthening its platform for growth in rare blood disorders," the group said.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
The offer will be launched at a price of 45.00 euros per share or ADS, 18.66 euros - 41.79 euros per warrant, 393,700.78 euros per convertible bond.
"With Ablynx's innovative Nanobody® technology platform, Sanofi will continue to advance the strategic transformation of its Research and Development strategy, expanding its late-stage pipeline and strengthening its platform for growth in rare blood disorders," the group said.
Copyright (c) 2018 CercleFinance.com. All rights reserved.